Curogen’s Leadership is consisted with professional executive members with biotechnology and pharmaceutical backgrounds, collective experience, and broad visions for the future. Each one of our members leads us to broadening and developing our pipeline, and paves Curogen’s way into contributing to humanity’s health.
Chang-Woo Lee, Ph.D.
- · Harvard Medical School, Post-doctor
- · Univ of Glasgow/NIMR, PhD
- · Sungkyunkwan University School of Medicine, Professor
- · Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Professor
- · Ministry of Health and Welfare, Ministry of Trade, Industry and Energy, Ministry of Science and Technology: Advisory committee, Steering committee, Expert committee
- · Invited talk at Harvard Medical school, Mayo Clinic, Oxford Univ, etc
- · 2004~2023, Average SCI IF 17.075 for 20 selected journal publications as corresponding author